![](/img/cover-not-exists.png)
Peginterferon α-2a (40kD) [Pegasys®] Improves HR-QOL Outcomes Compared with Unmodified Interferon α-2a [Roferon®-A]
Dr Jens Rasenack,Stefan Zeuzem,S. Victor Feinman,E. Jenny Heathcote…Volume:
21
Language:
english
Journal:
PharmacoEconomics
DOI:
10.2165/00019053-200321050-00005
Date:
April, 2003
File:
PDF, 134 KB
english, 2003